Dexur helps Medical Device Organizations succeed by providing critical hospital specific quality outcomes & data.

Click here to learn about Dexur’s plans, pricing and benefits for Medical Device Organizations.

SCANLAN® In Situ Valvulotomes - SCANLAN INTERNATIONAL INC - In Depth Guide

SCANLAN INTERNATIONAL INC - SCANLAN® In Situ Valvulotomes : Product InformationBack to Top


 SCANLAN® In Situ Valvulotomes
 In Commercial Distribution
 SCANLAN INTERNATIONAL INC
 00846159032000
 GS1
 NA
 1
 Valvulotome

SCANLAN® In Situ Valvulotomes - Device Characteristics


MRI safety Status Labeling does not contain MRI Safety Information
Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437) No
Device labeled as "Not made with natural rubber latex" No
For Single-Use No
Prescription Use (Rx) True
Over the Counter (OTC) No
Kit No
Combination Product No
Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P) No

SCANLAN® In Situ Valvulotomes - GMDN


GMDN Preferred Term Name GMDN Definition
Valvulotome A hand-held manual surgical instrument designed for cutting an anatomical valve or valves in situ (e.g., to slit a heart valve or to cut the valves within a vein to allow blood flow in the opposite direction). It is typically a flexible, plastic-coated metal shaft with a proximal handle and an extremely sharp cutting edge at the distal tip (e.g., the distal tip may terminate in a blade which is curved at 90 degrees to the shaft, or an assembly of several thin helicoidal blades that are rotated). This is a reusable device.

SCANLAN® In Situ Valvulotomes - Sterilization


 No
 true

SCANLAN INTERNATIONAL INC - SCANLAN® In Situ Valvulotomes : Product Code InformationBack to Top


FDA Product Code

Product Code Product Code Name
MGZ Valvulotome

SCANLAN INTERNATIONAL INC - SCANLAN® In Situ Valvulotomes : Reimbursement Data & Quality OutcomesBack to Top


This sample data is for Yale New Haven Hospital & shows the reimbursement and quality outcomes data to help understand the the ROI, Business Case, HEOR & VAC Metrics in the use SCANLAN® In Situ Valvulotomes by SCANLAN INTERNATIONAL INC.
To get metrics for your Hospital, click here.

Quality Outcomes Data from Medicare Claims Analysis

Jan 2017 to Dec 2017 Medicare Hospitalizations Jan 2013 to Dec 2017 Medicare Hospitalizations
Inpatient (For Included Categories & DRGs) 181 870
Non Surgical (For Included Categories & DRGs) 181 870
Cardiovascular (For Included DRGs) 181 870
PERIPHERAL VASCULAR DISORDERS 181 870

Inpatient Quality Outcomes Data from Medicare Claims Analysis   |   Back to Reimbursement Quality Outcomes Summary


Data with Symbol is for Dexur Pro Members. Sign Up Now.

Inpatient All (For Included Categories & DRGs) Inpatient - Non Surgical (For Included Categories & DRGs)
Jan 2017 to Dec 2017 Jan 2013 to Dec 2017 Jan 2017 to Dec 2017 Jan 2013 to Dec 2017
Total Hospitalizations 181 870 181 870
Total Hospitalizations After Exclusion 172 821 172 821
Avg. LOS 4.10 4.42 4.10 4.42
All Cause Readmission Rate (%)
Unplanned Readmission Rate (%)
ICU Stays
Avg. Number of Days in ICU per ICU Stay
Total Medicare Payments $1,557,819 $8,154,220 $1,557,819 $8,154,220
Payment per Day $2,099 $2,119 $2,099 $2,119
Payment per Hospitalization $8,606 $9,372 $8,606 $9,372
Total Medicare Charges $6,149,265 $33,438,065 $6,149,265 $33,438,065
Avg. Charges $33,974 $38,435 $33,974 $38,435
Mortality Rate (%)
SNF Discharge Rate (%) 20.44 22.87 20.44 22.87
Home Discharge Rate (%) 31.49 32.76 31.49 32.76
Peripheral Vascular Disease
Total Hospitalizations with Peripheral Vascular Disease
Total Hospitalizations After Exclusion with Peripheral Vascular Disease
Avg. LOS with Peripheral Vascular Disease
30 Day Peripheral Vascular Disease Readmission Rate (%)
30 Day Readmission Rate with Peripheral Vascular Disease(%)
30 Day Peripheral Vascular Disease Unplanned Readmission Rate (%)
ICU Stays with Peripheral Vascular Disease
Avg. Number of Days in ICU per ICU Stay with Peripheral Vascular Disease
Medicare Payments with Peripheral Vascular Disease
Payment per Day with Peripheral Vascular Disease
Payment per Hospitalization with Peripheral Vascular Disease
Medicare Charges with Peripheral Vascular Disease
Avg. Charges with Peripheral Vascular Disease
Inpatient Hospital Mortality Rate (%) with Peripheral Vascular Disease
SNF Discharge Rate (%) with Peripheral Vascular Disease
Home Discharge Rate (%) with Peripheral Vascular Disease
Incidence Rate (%) with Peripheral Vascular Disease
Incidence Rate (%) with Peripheral Vascular Disease after Exclusions

Top ICD Diagnosis Codes For Inpatient (For Included Categories & DRGs)   |   Back to Reimbursement Quality Outcomes Summary


Data with Symbol is for Dexur Pro Members. Sign Up Now.

ICD Code ICD Description Total ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 Total ICD & DRG Hospitalization Volume - Jan 2017 to Dec 2017 % of DRG Volume - Jan 2013 to Dec 2017 % of DRG Volume - Jan 2017 to Dec 2017
4019 Unspecified essential hypertension 233 NA 26.78 NA

Top Procedure Codes For Inpatient (For Included Categories & DRGs)   |   Back to Reimbursement Quality Outcomes Summary


Data with Symbol is for Dexur Pro Members. Sign Up Now.

Procedure Code Procedure Description Total Procedure Code & DRG Hospitalization Volume - Jan 2013 to Dec 2017 Total Procedure Code & DRG Hospitalization Volume - Jan 2017 to Dec 2017 % of DRG Volume - Jan 2013 to Dec 2017 % of DRG Volume - Jan 2017 to Dec 2017
9919 46 NA 5.29 NA

Cardiovascular Quality Outcomes Data from Medicare Claims Analysis   |   Back to Reimbursement Quality Outcomes Summary


Data with Symbol is for Dexur Pro Members. Sign Up Now.

Cardiovascular (For Included DRGs) Cardiovascular - Non Surgical (For Included DRGs)
Jan 2017 to Dec 2017 Jan 2013 to Dec 2017 Jan 2017 to Dec 2017 Jan 2013 to Dec 2017
Total Hospitalizations 181 870 181 870
Total Hospitalizations After Exclusion 172 821 172 821
Avg. LOS 4.10 4.42 4.10 4.42
All Cause Readmission Rate (%)
Unplanned Readmission Rate (%)
ICU Stays
Avg. Number of Days in ICU per ICU Stay
Total Medicare Payments $1,557,819 $8,154,220 $1,557,819 $8,154,220
Payment per Day $2,099 $2,119 $2,099 $2,119
Payment per Hospitalization $8,606 $9,372 $8,606 $9,372
Total Medicare Charges $6,149,265 $33,438,065 $6,149,265 $33,438,065
Avg. Charges $33,974 $38,435 $33,974 $38,435
Mortality Rate (%)
SNF Discharge Rate (%) 20.44 22.87 20.44 22.87
Home Discharge Rate (%) 31.49 32.76 31.49 32.76
Peripheral Vascular Disease
Total Hospitalizations with Peripheral Vascular Disease
Total Hospitalizations After Exclusion with Peripheral Vascular Disease
Avg. LOS with Peripheral Vascular Disease
30 Day Peripheral Vascular Disease Readmission Rate (%)
30 Day Readmission Rate with Peripheral Vascular Disease(%)
30 Day Peripheral Vascular Disease Unplanned Readmission Rate (%)
ICU Stays with Peripheral Vascular Disease
Avg. Number of Days in ICU per ICU Stay with Peripheral Vascular Disease
Medicare Payments with Peripheral Vascular Disease
Payment per Day with Peripheral Vascular Disease
Payment per Hospitalization with Peripheral Vascular Disease
Medicare Charges with Peripheral Vascular Disease
Avg. Charges with Peripheral Vascular Disease
Inpatient Hospital Mortality Rate (%) with Peripheral Vascular Disease
SNF Discharge Rate (%) with Peripheral Vascular Disease
Home Discharge Rate (%) with Peripheral Vascular Disease
Incidence Rate (%) with Peripheral Vascular Disease
Incidence Rate (%) with Peripheral Vascular Disease after Exclusions

Top ICD Diagnosis Codes for Cardiovascular (For Included Categories & DRGs)   |   Back to Reimbursement Quality Outcomes Summary


Data with Symbol is for Dexur Pro Members. Sign Up Now.

ICD Code ICD Description Total ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 Total ICD & DRG Hospitalization Volume - Jan 2017 to Dec 2017 % of DRG Volume - Jan 2013 to Dec 2017 % of DRG Volume - Jan 2017 to Dec 2017
4019 Unspecified essential hypertension 233 NA 26.78 NA

Top Procedure Codes for Cardiovascular (For Included Categories & DRGs)   |   Back to Reimbursement Quality Outcomes Summary


Data with Symbol is for Dexur Pro Members. Sign Up Now.

Procedure Code Procedure Description Total Procedure Code & DRG Hospitalization Volume - Jan 2013 to Dec 2017 Total Procedure Code & DRG Hospitalization Volume - Jan 2017 to Dec 2017 % of DRG Volume - Jan 2013 to Dec 2017 % of DRG Volume - Jan 2017 to Dec 2017
9919 46 NA 5.29 NA

DRG Group : PERIPHERAL VASCULAR DISORDERS Quality Outcomes Data from Medicare Claims Analysis   |   Back to Reimbursement Quality Outcomes Summary


Data with Symbol is for Dexur Pro Members. Sign Up Now.

PERIPHERAL VASCULAR DISORDERS - Cardiovascular DRG 300 : PERIPHERAL VASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY DRG 299 : PERIPHERAL VASCULAR DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY DRG 301 : PERIPHERAL VASCULAR DISORDERS WITHOUT COMPLICATION OR COMORBIDITY/MAJOR COMPLICATION OR COMORBIDITY
DRG Group PERIPHERAL VASCULAR DISORDERS PERIPHERAL VASCULAR DISORDERS PERIPHERAL VASCULAR DISORDERS PERIPHERAL VASCULAR DISORDERS
Jan 2017 to Dec 2017 Jan 2013 to Dec 2017 Jan 2017 to Dec 2017 Jan 2013 to Dec 2017 Jan 2017 to Dec 2017 Jan 2013 to Dec 2017 Jan 2017 to Dec 2017 Jan 2013 to Dec 2017
Total Hospitalizations 181 870 99 483 48 235 34 152
Total Hospitalizations After Exclusion 172 821 93 464 46 215 33 142
Avg. LOS 4.10 4.42 3.87 4.16 5.79 6.17 2.38 2.55
All Cause Readmission Rate (%)
Unplanned Readmission Rate (%)
ICU Stays
Avg. Number of Days in ICU per ICU Stay
Total Medicare Payments $1,557,819 $8,154,220 $780,025 $4,175,552 $590,784 $3,116,383 $187,009 $862,284
Payment per Day $2,099 $2,119 $2,036 $2,077 $2,125 $2,147 $2,308 $2,228
Payment per Hospitalization $8,606 $9,372 $7,879 $8,645 $12,308 $13,261 $5,500 $5,672
Total Medicare Charges $6,149,265 $33,438,065 $3,010,082 $16,832,672 $2,273,222 $12,757,070 $865,961 $3,848,323
Avg. Charges $33,974 $38,435 $30,405 $34,850 $47,359 $54,285 $25,469 $25,318
Mortality Rate (%)
SNF Discharge Rate (%) 20.44 22.87 19.19 22.98 27.08 28.94 NA 13.16
Home Discharge Rate (%) 31.49 32.76 30.30 31.68 25.00 23.83 44.12 50.00
Peripheral Vascular Disease
Total Hospitalizations with Peripheral Vascular Disease
Total Hospitalizations After Exclusion with Peripheral Vascular Disease
Avg. LOS with Peripheral Vascular Disease
30 Day Peripheral Vascular Disease Readmission Rate (%)
30 Day Readmission Rate with Peripheral Vascular Disease(%)
30 Day Peripheral Vascular Disease Unplanned Readmission Rate (%)
ICU Stays with Peripheral Vascular Disease
Avg. Number of Days in ICU per ICU Stay with Peripheral Vascular Disease
Medicare Payments with Peripheral Vascular Disease
Payment per Day with Peripheral Vascular Disease
Payment per Hospitalization with Peripheral Vascular Disease
Medicare Charges with Peripheral Vascular Disease
Avg. Charges with Peripheral Vascular Disease
Inpatient Hospital Mortality Rate (%) with Peripheral Vascular Disease
SNF Discharge Rate (%) with Peripheral Vascular Disease
Home Discharge Rate (%) with Peripheral Vascular Disease
Incidence Rate (%) with Peripheral Vascular Disease
Incidence Rate (%) with Peripheral Vascular Disease after Exclusions

Top ICD Diagnosis Codes for PERIPHERAL VASCULAR DISORDERS   |   Back to Reimbursement Quality Outcomes Summary


Data with Symbol is for Dexur Pro Members. Sign Up Now.

ICD Code ICD Description Total ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 Total ICD & DRG Hospitalization Volume - Jan 2017 to Dec 2017 % of DRG Volume - Jan 2013 to Dec 2017 % of DRG Volume - Jan 2017 to Dec 2017
4019 Unspecified essential hypertension 233 NA 26.78 NA

Top Procedure Codes for PERIPHERAL VASCULAR DISORDERS   |   Back to Reimbursement Quality Outcomes Summary


Data with Symbol is for Dexur Pro Members. Sign Up Now.

Procedure Code Procedure Code Description Total Procedure Code & DRG Hospitalization Volume - Jan 2013 to Dec 2017 Total Procedure Code & DRG Hospitalization Volume - Jan 2017 to Dec 2017 % of DRG Volume - Jan 2013 to Dec 2017 % of DRG Volume - Jan 2017 to Dec 2017
9919 46 NA 5.29 NA

Physicians Who May Use SCANLAN INTERNATIONAL INC - SCANLAN® In Situ Valvulotomes Back to Top


This sample data is for Yale New Haven Hospital & shows the top physicians that may be impacted by use of SCANLAN® In Situ Valvulotomes by SCANLAN INTERNATIONAL INC.
To get physicians impacted for your Hospital, click here.

Data from Medicare Claims Analysis

Physician Name Total Hospitalizations - Jan 2013 to Dec 2017 Total Hospitalizations - Jan 2017 to Dec 2017
DR. CARLOS I MENA-HURTADO 61 12
DR. JOHN A ELEFTERIADES 15 NA
DR. CASSIUS IYAD N OCHOA CHAAR 13 NA